Alcohol en kanker.*

Onderzoekers van de universiteit van Mississippi hebben vastgesteld aan de de hand van muizenstudies hoe alcoholconsumptie tumoren doet groeien. De hoeveelheid alcohol die de muizen kregen is te vergelijken met 2-4 glazen per dag voor mensen. De gevolgen van deze alcohol waren: een tumor die wel twee keer zo groot was, de aanmaak van veel capillaire vaatjes, de tumors hadden wel twee keer zoveel bloedvaten en de hoeveelheid VEGF ( een stof die een sleutelrol speelt bij de aanmaak van nieuwe bloedvaten) was duidelijk verhoogd. VEGF heeft het lichaam nodig voor de aanmaak van nieuwe bloedvaten waardoor weefsels kunnen groeien doch bij het ontstaan van tumoren doet een teveel ervan de tumor verder groeien.

Cellen houden niet van alcohol omdat het heel moeilijk af te breken is. Uiteindelijk vergt de afbraak ervan zoveel zuurstof dat er een tekort in de cel ontstaat. Indirect wordt daardoor de productie van VEGF gestimuleerd waardoor nieuwe bloedvaatjes aangemaakt worden om aan de vraag van zuurstof te kunnen voldoen.

Equivalent Of 2-4 Drinks Daily Encourages Cancer Tumors In Mice

University of Mississippi researchers say they have created the first-ever mammalian model of how alcohol consumption spurs tumor growth, showing that even moderate drinking resulted in larger and more robust tumors.
The research provides the first mammalian model of the links between alcohol, VEGF, and tumor growth, said Wei Tan, the study's lead author. The study increases understanding of how alcohol over-stimulates production of vascular endothelial growth factor (VEGF) -- a substance that the body needs, but which can be harmful when there is too much of it.
The new mouse model could lead to a way to block VEGF over-production, a step that could reduce the incidence of cancer and has important implications for cancer education and prevention. Wei Tan, Megan Shparago, Amelia P. Bailey and Jian-Wei Gu of the University of Mississippi Medical Center will present "Moderate alcohol intake stimulates tumor angiogenesis and expression of vascular endothelial growth factor (VEGF) in a mouse model," at the Experimental Biology Conference 2006 in San Francisco.
The study earned Tan a Caroline tum Suden/Frances A. Hellebrandt Professional Opportunity Award from the American Physiological Society (APS) for exemplary research. The presentation was part of the scientific program sponsored by APS.
*Paper presentation: "Moderate alcohol intake stimulates tumor angiogenesis and expression of vascular endothelial growth factor (VEGF) in a mouse model," 12:45 p.m. - 3 p.m. Monday April 3, Angiogenesis and Vascular Growth, 462.3 /board # C264. On view 7:30 a.m. to 6 p.m., Convention Center Exhibit Hall. Research was by Wei Tan, Megan Shparago, Amelia P. Bailey and Jian-Wei Gu of the Department of Physiology, University of Mississippi Medical Center, Jackson, MS.
Researchers develop mouse model
Unlike studies which use alcohol that would be the equivalent of high consumption in humans, the researchers gave mice a more moderate dose -- the equivalent to 2-4 glasses of alcohol per day.
Six male mice received 1% alcohol in their drinking water for eight hours each night during the four-week experiment, Tan said. The six mice in the control group received plain water. In the second week, the researchers injected the mice, both experimental and controls, with mouse melanoma. They ended the experiment after four weeks.
According to Tan, the tumors of the mice that ingested alcohol:
* were nearly twice as heavy compared to the mice that did not have alcohol
* showed a dramatic increase in new micro-vessels, that is, blood vessels that cannot be seen with the naked eye, such as capillaries
* were nearly twice as dense with blood vessels
* showed a significant increase in VEGF
Alcohol long identified as cancer risk "It's very important to have a model of how to prevent cancer," and this study provides that model, Gu said. "Epidemiologists have recognized alcohol as a risk factor for cancer for 100 years," but this study examines how that happens.
The mouse study builds on an earlier study with chicks that showed alcohol consumption increased the expression of a protein known as VEGF. VEGF fuels tumor growth by spurring the development of blood vessels in cancer cells that might otherwise die.
Normally, the immune system can kill off small tumors. However, when they grow large enough the body can no longer fight off the tumor cells. This is why angiogenesis is so important, Gu said.
VEGF, a protein that stimulates formation of blood vessels, helps organ tissues grow. Unfortunately, it also aids tumors grow by helping them develop a system of blood vessels. Without these blood vessels, cancer cells that form small tumors would quickly die.
The vast majority of tumors result from over expressed VEGF, Gu explained. "Every day, we produce a lot of cancer cells, but they don't become bigger," he said. But if the cell establishes blood vessels, the tumor grows and strengthens, a process known as angiogenesis.
Cells dislike alcohol
When alcohol is consumed, it enters the cells, which attempt to eliminate it. Because it is difficult to break it down, the cells must increase metabolic activity to do that, Tan explained. But that requires oxygen, and the cells may deplete themselves of oxygen in an attempt to break down the alcohol.
This oxygen-depletion, known as hypoxia, indirectly induces production of VEGF. VEGF, in turn, stimulates the growth of new blood vessels to meet the increased oxygen demand. It is still too early to define safe levels of alcohol consumption in humans, Tan said, but she advises caution when drinking, particularly for individuals who drink every day.
"If you have risk for any kind of cancer, don't drink at all," Gu advised. For those not at risk, the occasional social drink is fine, but "I don't think 2-4 drinks per day is okay," Gu ventured. The public needs to know of these results as a tool of cancer prevention. Gu was once approached by a man on chemotherapy who asked him if it was okay to drink. The answer was a firm "no."
###
Funding: National Institutes of Health.
Editor's Note: For further information or to schedule an interview with a member of the research team, please contact Christine Guilfoy at the APS newsroom @ 415.905.1024 (March 31-April 5); or 978.290.2400 (cell) or after EB at 301.634.7253 (office) or cguilfoy@the-aps.org; or, Mayer Resnick at 301.332.4402 (cell) or 301.634.7209 (office).
Go to http://www.faseb.org/meetings/eb2006/call/ and click on "Searchable Program Planner and Itinerary Builder to find the searchable online program for EB.
The American Physiological Society was founded in 1887 to foster basic and applied bioscience. The Bethesda, Maryland-based society has more than 10,000 members and publishes 14 peer-reviewed journals containing 4,000 articles annually.
APS provides a wide range of research, education and career support and programming to further the contributions of physiology to understanding the mechanisms of diseased and healthy states. In May 2004, APS received the Presidential Award for Excellence in Science, Mathematics and Engineering Mentoring.
Experimental Biology is an annual scientific meeting convened by the Federation of American Societies of Experimental Biology, including the American Physiological Society (APS) and other biomedical societies. The meeting features "nominated" lectures, symposia, research presentations, awards, a job placement center, and an exhibit of scientific equipment, supplies, and publications. This year's participating Societies are APS, American Association of Anatomists, American Society for Biochemistry and Molecular Biology, American Society for Investigative Pathology, American Society for Nutritional Sciences, and the American Society for Pharmacology and Experimental Therapeutics.
Christine Guilfoy
cguilfoy@the-aps.org (mei 2006)